SGTX(Delisted)
SigilonยทNASDAQ
--
--(--)
SGTX Profile
Sigilon Therapeutics, Inc.
A biotech company that develops and commercializes therapies for the treatment of cronic diseases
100 Binney Street, Suite 600, Cambridge, MA 02142
--
Sigilon Therapeutics, Inc., was incorporated under the laws of Delaware on May 14, 2015 as Sigilon, Inc., and changed its name in July 2017. The company is a clinical-stage biotechnology company pioneering the development of novel therapies and seeking to develop functional therapies for patients with chronic diseases by delivering stable and durable levels of therapeutic molecules to patients.
